Provided by Tiger Trade Technology Pte. Ltd.

Arcturus Therapeutics Ltd.

15.19
-0.9800-6.06%
Pre-market: 14.92-0.2683-1.77%07:17 EDT
Volume:1.62M
Turnover:24.27M
Market Cap:431.59M
PE:-4.56
High:15.90
Open:15.43
Low:14.49
Close:16.17
52wk High:24.17
52wk Low:5.50
Shares:28.41M
Float Shares:26.28M
Volume Ratio:0.75
T/O Rate:6.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3289
EPS(LYR):-2.4021
ROE:-46.31%
ROA:-23.96%
PB:2.51
PE(LYR):-6.32

Loading ...

Arcturus Therapeutics initiated with a Buy at Freedom Broker

TIPRANKS
·
Jul 02

Arcturus Therapeutics to Present at Jefferies Global Healthcare Conference

Reuters
·
May 27

ARCT Rating Reiterated at Hold as High-Risk ARCT-032 CF Program Awaits Binary Phase 2 Readout; $9 Price Target Maintained

TIPRANKS
·
May 13

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.
·
May 12

Arcturus Therapeutics Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Arcturus Therapeutics Holdings Inc - Appoints Dennis Mulroy as CFO Effective May 1, 2026 - SEC Filing

THOMSON REUTERS
·
May 08

Arcturus Therapeutics CFO Dennis Mulroy files initial beneficial ownership statement

Reuters
·
May 08

Arcturus Q1 FY26 net loss widens to $27 million; revenue drops to $2.06 million

Reuters
·
May 08

BRIEF-Arcturus Therapeutics Q1 Net Income USD -26.964 Million

Reuters
·
May 08

Arcturus Therapeutics Q1 Collaboration Revenue USD 610 Thousand

THOMSON REUTERS
·
May 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 07

Arcturus Therapeutics Holdings Inc expected to post a loss of $1.09 a share - Earnings Preview

Reuters
·
May 06

Arcturus Therapeutics updates financial calendar with first-quarter results conference call

Reuters
·
Apr 28

Press Release: Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026

Dow Jones
·
Apr 28

Arcturus Therapeutics announces annual shareholder meeting

Reuters
·
Apr 25

Roth MKM Remains a Buy on Arcturus Therapeutics (ARCT)

TIPRANKS
·
Apr 15

Roth MKM Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)

TIPRANKS
·
Mar 27

Arcturus Therapeutics Holdings Inc : B. Riley Initiates Coverage With Buy Rating; Price Target $22

THOMSON REUTERS
·
Mar 18

Arcturus Therapeutics initiated with a Buy at B. Riley

TIPRANKS
·
Mar 18

U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

Reuters
·
Mar 18